Kamil Ali-Jackson, Chief Legal Officer at Aclaris Therapeutics, Inc. (ACRS), sold 38,732 shares at $23.32 ($907K) on 2021-05-06, disclosed to the SEC on 2021-05-07.
Open-market sale of $907k ACRS by Chief Legal Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.32 | 11,898 | $277K | 30.6% |
| 2 | $23.32 | 11,898 | $277K | 30.6% |
| 3 | $23.86 | 3,102 | $74K | 8.2% |
| 4 | $23.86 | 3,102 | $74K | 8.2% |
| 5 | $23.23 | 3,316 | $77K | 8.5% |
| 6 | $23.23 | 3,316 |
| $77K |
| 8.5% |
| 7 | $23.99 | 2,100 | $50K | 5.6% |
| Total | $23.43 avg | 38,732 | $907K | 100% |
| Filing → |
| PDSB | BUY | 2021-06-17 | $100K | — | Filing → |
| ACRS | SELL | 2021-06-04 | $417K | — | Filing → |
| ACRS | SELL | 2021-06-02 | $2.0M | — | Filing → |